Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Department of Physiology, Division of Nutrition Physiology, Sao Paulo Federal University, Sao Paulo, Brazil
Lipidomics and Nutrition Research Centre, Faculty of Life Sciences and Computing, London Metropolitan University, London, United Kingdom
c
Department of Medicine, Division of Infectious Diseases, Section of Paediatrics, Institute of Reproductive and Developmental Biology, Imperial College
London, London, United Kingdom
d
Institute of Science and the Environment, University of Worcester, Worcester, United Kingdom
b
art ic l e i nf o
a b s t r a c t
Article history:
Received 21 December 2014
Received in revised form
28 August 2015
Accepted 1 October 2015
Altered tissue fatty acid (FA) composition may affect mechanisms involved in the control of energy
homeostasis, including central insulin actions. In rats fed either standard chow or a lard-enriched chow
(high in saturated/low in polyunsaturated FA, HS-LP) for eight weeks, we examined the FA composition
of blood, hypothalamus, liver, and retroperitoneal, epididymal and mesenteric adipose tissues. Insulininduced hypophagia and hypothalamic signaling were evaluated after intracerebroventricular insulin
injection.
HS-LP feeding increased saturated FA content in adipose tissues and serum while it decreased
polyunsaturated FA content of adipose tissues, serum, and liver. Hypothalamic C20:5n-3 and C20:3n-6
contents increased while monounsaturated FA content decreased. HS-LP rats showed hyperglycemia,
impaired insulin-induced hypophagia and hypothalamic insulin signaling.
The results showed that, upon HS-LP feeding, peripheral tissues underwent potentially deleterious
alterations in their FA composition, whist the hypothalamus was relatively preserved. However, hypothalamic insulin signaling and hypophagia were drastically impaired. These ndings suggest that
impairment of hypothalamic insulin actions by HS-LP feeding was not related to tissue FA composition.
& 2015 Elsevier Ltd. All rights reserved.
Keywords:
Fatty acid
Obesity
Diet
Insulin signaling
Adipose tissue
Hypothalamus
1. Introduction
The hypothalamus is one of the major structures of the central
nervous system involved in metabolic sensing and hormone
feedback. Appetite and energy expenditure are nely tuned by a
combination of central and peripheral signals, including acute
hormonal signals of hunger and satiety, as well as hormonal signals related to long-term control of adiposity [1,2]. Neural and
hormonal inputs act in anabolic and catabolic hypothalamic
effector systems, modulating food intake and energy expenditure
in response to physiological needs in energy metabolism.
In the hypothalamus, insulin binds to insulin receptors present
in areas involved in the control of food intake, including the arcuate nucleus and the ventromedial hypothalamus [35]. The initial
http://dx.doi.org/10.1016/j.plefa.2015.10.003
0952-3278/& 2015 Elsevier Ltd. All rights reserved.
22
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
2. Methods
2.1. Animals
This study was approved by the Sao Paulo Federal University
Research Ethics Committee, and all the procedures were carried out
in full compliance with its ethical guidelines. Fifty eight male Wistar
rats, weaned on the 21st day of life, were obtained from CEDEME
(Centro de Desenvolvimento de Modelos Experimentais para
Medicina e Biologia), and housed (four to ve rats per cage) in the
animal house of the Division of Nutrition Physiology, Sao Paulo
Federal University, under controlled lighting (12 h light/dark cycle,
lights on at 6:00) and temperature (2271 C), with free access to
standard rat chow and water. After two weeks acclimatization the
rats were randomised into two groups, and fed a standard rat chow
(Control) or lard-enriched chow (high in saturated/low in polyunsaturated FA, HS-LP) ad libitum for 8 weeks, as described below.
Table 1
Total energy calorie value (kcal/g), protein content, carbohydrates, alimentary ber,
mineral residues (g/100 g) and fatty acid composition (% of total fatty acids) of
control chow and lard-en riched chow.
Control chow
Lard-enriched chow
Energy (kcal/g)
Protein (g/100 g)
Carbohydrates (g/100 g)
Alimentary ber (g/100 g)
Mineral residues (g/100 g)
Total fat
2.7
22.4
39.1
11.4
11.9
4.8
4.1
23.6
26.8
15.1
9
22
0.1
12.3
2.4
14.8
5.1
1
20.9
10.9
32.8
1.9
c16:1n7
c18:1n9
c18:1n7
c20:1
MUFA
0
24.6
1.1
0.2
25.9
1.7
36
2.3
0.6
40.5
c18:3n3
c18:2n6
PUFA
n-6/n-3
4.1
54.9
59
13.3
1.4
23.1
24.5
16.6
SFA/PUFA
0.3
1.3
2.2. Diets
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
*
***
**
**
**
**
**
0
1
4
Weeks
40
30
20
10
0
1
4
Weeks
500
Body weight (g)
HS-LP
12
Food intake
(g/100g/24h)
Energy intake
(Kcal/100g/24h)
23
400
*#
300
*#
*#
*#
#
***
*#
#
***
200
100
1
3. Results
3.1. Food and energy intake and body weight
60-day old male Wistar rats were treated for 8 weeks with a
standard rat chow (Control) or a lard-enriched diet (HS-LP). During the course of the 8 weeks treatment, weekly-measured 24 h
Weeks
Fig. 1. Food (g/100 g BW/24 h, upper panel) and energy (kcal/100 g BW/24 h,
middle panel) intake and body weight (g, lower panel) of male rats treated with a
standard rodent chow (2.7 kcal/g, 15% energy from fat) or lard-enriched chow
(4.1 kcal/g, 52% energy from fat) for 8 weeks. Error bars indicate standard error of
the mean. N 20 for each group.
n
p o0.05 HS-LP vs. Control; nnp o0.01 HS-LP vs. Control; nnnp o 0.001 HS-LP vs.
Control.
24
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
Retroperitoneal
Epididymal
Mesenteric
Control
HS-LP
0.717 0.04
0.82 7 0.05
0.707 0.04
104.77 3.7
0.8 7 0.1
1.40 70.09nnn
1.47 70.10nnn
1.30 70.08nnn
119.6 76.3*
1.0 70.2
nnn
Table 3
Fatty acid composition of liver, serum and hypothalamus total lipid extract of male Wistar rats treated with a standard rodent chow (Control, 2.7 kcal/g, 15% energy from fat)
or lard-enriched chow (HS-LP, 4.1 kcal/g, 52% energy from fat) for 8 weeks. Data are presented as means 7 SEM of total FAs (%). n 5 for each group.
Fatty acid
C14:0
C16:0
C18:0
C24:0
SFA
C16:0/C18:0
C16:1n-7
C18:1n-9
C18:1n-7
C20:1
C24:1
MUFA
C18:0/C18:1
C18:3n-3
C20:5n-3
C22:5n-3
C22:6n-3
n-3
C18:2n-6
C18:3n-6
C20:3n-6
C20:4n-6
C22:4n-6
C22:5n-6
n-6
PUFA
n-6/n-3
SFA/PUFA
Serum
Control
HS-LP
0.3 7 0.04
17.6 7 0.48
14.7 7 0.44
0.5 7 0.02
337 0.51
1.2 7 0.06
0.7 7 0.15
7.3 7 0.25
3.3 7 0.17
0.2 7 0.02
0.2 7 0.01
11.7 7 0.43
1.4 7 0.07
0.3 7 0.03
0.3 7 0.02
1.5 7 0.11
57 0.49
7.17 0.37
187 0.74
0.3 7 0.01
0.6 7 0.02
25.17 0.39
0.9 7 0.03
0.2 7 0.05
457 0.7
52.17 0.75
6.4 7 0.35
0.6 7 0.02
0.2 7 0.03
16.8 7 0.65
16.17 1.56
0.3 7 0.04
33.4 7 0.93
1.17 0.12
0.4 7 0.04
17.5 7 1.87
27 0.13
0.3 7 0.04
0.17 0.02
20.3 7 2.05
0.9 7 0.23
0.2 7 0.03
0.2 7 0.07
1.17 0.08
3.7 7 0.16
5.2 7 0.21
15.5 7 0.44
0.4 7 0.03
0.5 7 0.02
20.17 1.7
1.5 7 0.15
0.9 7 0.17
38.9 7 1.14
44.17 1.31
7.5 7 0.17
0.8 7 0.01
nn
nn
nnn
n
nn
n
n
nn
n
nn
n
nn
nn
nn
nn
n
nnn
Hypothalamus
Control
HS-LP
Control
HS-LP
0.4 70.02
20.4 70.41
12 70.26
0.2 70.02
32.9 70.46
1.7 70.06
0.8 70.12
9.5 70.44
2 70.14
0.1 70.03
0.1 70.01
12.6 70.5
1 70.05
0.4 70.02
0.5 70.05
0.9 70.05
2.5 70.22
4.3 70.18
20.5 70.37
0.2 70.01
0.3 70.03
26.1 70.4
0.6 70.06
0.1 70.03
47.9 70.66
52.3 70.72
11.1 70.5
0.6 70.02
0.3 7 0.02
197 0.39
18.3 7 0.48
0.17 0.01
37.7 7 0.69
17 0.03
0.5 7 0.03
10.9 7 0.71
1.17 0.02
0.2 7 0.02
0.17 0.04
12.7 7 0.75
1.6 7 0.12
0.17 0.02
0.2 7 0.03
0.6 7 0.04
2.4 7 0.14
3.2 7 0.12
11.5 7 0.59
0.2 7 0.03
0.3 7 0.02
31.4 7 1.33
0.6 7 0.11
0.5 7 0.11
44.4 7 0.67
47.6 7 0.71
13.7 7 0.53
0.8 7 0.02
nn
0.17 0.01
19.9 70.35
18.17 0.2
0.3 7 0.04
38.4 7 0.46
1.1 70.02
0.5 7 0.02
20.9 7 0.22
47 0.12
1.1 70.05
0.05 7 0.01
26.5 7 0.37
0.7 7 0.01
0.047 0.02
0.077 0.01
1.08 7 0.31
137 0.78
14.2 70.89
1.4 7 0.42
ND
0.2 7 0.01
10.7 70.43
3.4 7 0.07
0.4 7 0.01
16.17 0.12
30.3 7 1.01
1.2 7 0.07
1.3 7 0.06
0.17 0.01
207 0.2
187 0.16
0.3 70.02
38.4 70.27
1.17 0.01
0.4 70.02
20.2 70.15
3.6 70.09
1.17 0.05
0.05 70.01
25.4 70.2
0.8 70.01
0.05 70.01
0.137 0.01
0.63 70.08
14.7 7 0.33
15.5 7 0.36
1.3 7 0.19
ND
0.3 70.01
11.17 0.18
3.4 70.06
0.3 70.01
16.4 7 0.24
31.9 7 0.51
1.17 0.02
1.2 7 0.03
n
nnn
nnn
nnn
n
nnn
nn
nnn
nn
nn
nn
nnn
n
nn
nnn
nn
nn
nn
nnn
n
n
nn
nn
nnn
SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; DHA: docosahexaenoic acid, EPA: eicosapentaenoic acid, ND: not detected.
n
p o0.05.
p o0.01.
nnn
p o 0.001.
nn
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
25
Table 4
Fatty acid composition of retroperitoneal, epididymal and mesenteric white adipose tissue total lipid extract of male Wistar rats treated with a standard rodent chow
(Control, 2.7 Kcal/g, 15% energy from fat) or lard-enriched chow (HS-LP, 4.1 Kcal/g, 52% energy from fat) for 8 weeks. Data are presented as means 7 SEM of total FAs (%). n
5 for each group.
Total fatty acids (%)
Fatty acid
C14:0
C16:0
C18:0
C24:0
SFA
C16:0/C18:0
C16:1n-7
C18:1n-9
C18:1n-7
C20:1
C24:1
MUFA
C18:0/C18:1
C18:3n-3
C20:5n-3
C22:5n-3
C22:6n-3
n-3
C18:2n-6
C18:3n-6
C20:3n-6
C20:4n-6
C22:4n-6
C22:5n-6
n-6
PUFA
n-6/n-3
SFA/PUFA
Retroperitoneal
Epididymal
Control
HS-LP
0.8 70.05
20.3 70.31
2.7 70.14
ND
23.9 70.37
7.5 7 0.42
2.8 70.5
24.27 0.2
2.7 70.12
0.2 70.01
ND
29.9 70.68
0.17 0.01
2.4 70.06
0.09 70.02
0.3 70.04
0.337 0.03
3.2 70.11
39.17 0.68
0.117 0.01
0.2 70.02
1.6 7 0.12
0.4 70.03
0.09 70.01
41.5 70.67
44.6 7 0.75
13.1 70.35
0.5 70.01
0.9 7 0.04
22 70.23
5.9 7 0.23
ND
28.8 7 0.12
3.7 7 0.17
2.4 7 0.16
39.8 7 0.24
2.8 7 0.03
0.3 7 0.01
ND
45.3 7 0.22
0.147 0.01
0.9 7 0.01
0.06 70.03
0.17 0.01
0.08 7 0.02
1.17 0.05
22.9 7 0.17
0.04 70.01
0.077 0.01
0.5 7 0.08
0.17 0.03
0.04 70.01
23.7 7 0.09
24.77 0.12
21.9 70.89
1.2 70.01
nn
nnn
nnn
nnn
nnn
nnn
nnn
nn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
n
nnn
nnn
nnn
nnn
Mesenteric
Control
HS-LP
0.8 7 0.03
20.8 7 0.23
37 0.04
ND
24.67 0.21
77 0.14
2.17 0.08
257 0.3
2.7 7 0.15
0.2 7 0.01
ND
307 0.41
0.117 0
2.3 7 0.08
0.067 0.001
0.2 7 0.02
0.167 0.02
2.7 7 0.1
39.7 7 0.44
0.08 7 0.01
0.147 0.01
17 0.09
0.3 7 0.03
0.067 0.01
41.2 7 0.43
43.9 7 0.49
15.3 70.47
0.6 7 0.01
0.8 70.03
21.8 7 0.12
6.3 70.05
ND
28.9 70.13
3.5 70.04
1.7 7 0.1
41.4 70.3
2.8 70.05
0.4 70.02
ND
46.4 70.19
0.14 70.001
0.7 70.03
0.05 70.02
0.17 0.001
0.05 70.01
0.9 70.04
22.4 70.21
0.02 70.01
0.08 70.01
0.3 70.04
0.17 0.03
0.04 7 0.01
22.9 70.17
23.8 70.2
26.9 71.16
1.2 7 0.01
nn
nnn
nnn
nnn
n
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nn
nnn
nn
nnn
nnn
nnn
nnn
Control
HS-LP
0.6 7 0.04
19.3 7 0.39
3.2 7 0.09
ND
23.2 7 0.45
67 0.18
1.3 7 0.12
25.9 7 0.3
2.7 7 0.1
0.2 7 0.01
ND
30.1 70.45
0.117 0
27 0.11
0.05 7 0.001
0.2 7 0.02
0.157 0.01
2.4 7 0.1
41.5 7 0.61
0.077 0.01
0.117 0.01
0.8 7 0.03
0.3 7 0.02
0.05 7 0.01
42.8 7 0.61
45.1 70.69
18.2 70.59
0.5 7 0.02
0.7 7 0.02
20.2 7 0.12
7.8 70.21
ND
28.8 7 0.19
2.6 7 0.08
1.2 70.02
42.2 7 0.16
2.9 7 0.04
0.5 7 0.01
ND
46.8 7 0.17
0.177 0.01
0.6 7 0.01
0.03 7 0.01
0.17 0.001
0.05 7 0.01
0.7 7 0.02
21.9 7 0.11
0.017 0
0.05 7 0.01
0.3 7 0.02
0.17 0.02
0.02 7 0.01
22.4 7 0.11
23.17 0.13
30 70.81
1.2 70.01
n
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nnn
nn
nnn
nnn
nnn
nnn
nnn
nnn
RET: retroperitoneal white adipose tissue; EPI: epididymal white adipose tissue; MES: mesenteric white adipose tissue; DHA: docosahexaenoic acid; EPA: eicosapentaenoic
acid; SFA: saturated fatty acids; MUFA: monounsaturated fatty acids; PUFA: polyunsaturated fatty acids; ND: not detected. Data are expressed as mean 7 SEM.
n
po 0.05.
p o0.01.
nnn
p o 0.001.
nn
4. Discussion
Obesity is a well characterized public health issue and its correlation with other health conditions is clear. Enlarged adipose
mass leads to increased peripheral vascular resistance, macrophage inltration, metabolic syndrome and mild chronic inammatory conditions [3436]. Chronic positive energy balance is the
main causal factor for the development of obesity, but often the
abundant intake of affordable, palatable, energy-dense foods
26
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
24
18
12
6
0
Control HS-LP
- +
- +
Control HS-LP
0-12
12-24
group
Control HS-LP
- +
- +
insulin
0-24
hours
Fig. 2. Food intake during the rst and second 12-h periods, and during the entire
24 h period after intracerebroventricular injection of vehicle (solid bars) or insulin
(striped bars) of male rats treated with a standard rodent chow (2.7 kcal/g, 15%
energy from fat) or lard-enriched chow (4.1 kcal/g, 52% energy from fat) for
8 weeks. Error bars indicate standard error of the mean. Control, n 2328; HS-LP,
n 1921.
#
p o 0.05 vs. respective vehicle-treated group.
Control
Control
HS-LP
-tubulin
150
100
50
pIR/-tubullin
-tubulin
300
200
100
0
0
Control
+
Control
HS-LP
Control
Control
HS-LP
Akt
pAkt
-tubulin
-tubulin
150
100
50
0
Control
HS-LP
pAkt/-tubulin
Akt/-tubulin
IR
IR
IR/-tubullin
HS-LP
200
+
HS-LP
Insulin
HS-LP
##
150
100
50
0
+
Control
+
HS-LP
Insulin
Fig. 3. Top panels (A and B): hypothalamic insulin receptor (IR) protein levels (a) and tyrosine phosphorylation (b) of Control (Control, n 78) and High-saturated/low-PUFA
(HS-LP, n 89) groups. Bottom panels (C and D): hypothalamic Akt protein levels (a) and serine phosphorylation (b) of Control (n 68) and HS-LP (n 67) groups. Rats
were treated with intracerebroventricularly injected vehicle ( ) or insulin ( ). Error bars indicate standard error of the mean. np o 0.05 HS-LP vs. Control; #p o0.05 vs. the
respective saline-treated group; ##p o 0.001 vs. the respective saline-treated group.
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
27
28
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
Authors' contribution
APSD, RLHW and AAB designed the research, conducted
laboratory work, analysed the results and wrote the paper. GDP,
VTB and YW conducted laboratory work, analysed the results and
wrote the paper. CMON and LMO designed the research, analysed
the results and wrote the paper. EBR is the Principal Investigator,
designed the research, analysed the results and wrote the paper.
All authors commented on the nal versions of the paper, and
share primary responsibility for its nal content.
Acknowledgments
This study was supported by Grants from the Sao Paulo
Research Foundation (FAPESP, Brazil) (Grant no. 2007/05360-4),
the National Council for Scientic and Technological Development
(CNPq, Brazil) (Grant no. 309405/2013-0), and the Coordination for
the Improvement of Higher Education Personnel (Capes, Brazil).
References
[1] E.B. Ribeiro, M.M. Telles, L.M. Oyama, et al., Hypothalamic Serotonin in the Control
of Food Intake: Physiological Interactions and Effect of Obesity, Focus on Nutrition
Research, Nova Science Publishers, New York, NY (2006), p. 121148.
[2] M.W. Schwatz, Central nervous system regulation of food intake, Obesity 14
(2006) 1S8S.
[3] D.G. Baskin, D.F. Lattermann, R.J. Seeley, et al., Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight,
Brain Res. 848 (1999) 114123.
[4] G.D. Pimentel, A.P. Dornellas, J.C. Rosa, et al., High-fat diets rich in soy or sh
oil distinctly alter hypothalamic insulin signaling in rats, J. Nutr. Biochem. 23
(2010) 822828.
[5] C. Ketterer, O. Tschritter, H. Preissl, et al., Insulin sensitivity of the human
brain, Diabetes Res. Clin. Pract. 1 (2011) 4751.
[6] J.B. Carvalheira, E.B. Ribeiro, E.P. Arajo, et al., Selective impairment of insulin
signaling in the hypothalamus of obese Zucker rats, Diabetologia 46 (2003)
16291640.
[7] K.D. Niswender, M.W. Schwartz, Insulin and leptin revisited: adiposity signals
with overlapping physiological and intracellular signaling capabilities, Front.
Neuroendocrinol. 24 (2003) 110.
[8] J.R. Zierath, H. Wallberg-Henriksson, From receptor to effector: insulin signal
transduction in skeletal muscle from type II diabetic patients, Ann. N.Y. Acad.
Sci. 967 (2002) 120134.
[9] Y. Du, T. Wei, Inputs and outputs of insulin receptor, Protein Cell 5 (2014)
203213.
[10] C. Huang, M. Wu, J. Du, et al., Systematic modeling for the insulin signaling
network mediated by IRS(1) and IRS(2), J. Theor. Biol 355 (2014) 4052, http:
//dx.doi.org/10.1016/j.jtbi.2014.03.030.
[11] K. Gerozissis, Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies, Eur. J. Pharmacol. 585 (2008) 3849.
[12] C.E. Batt, D. Rieger, S. Loureiro, et al., Alterations of PI3K and AKT signaling
pathways in the hippocampus and hypothalamus of Wistar rats treated with
highly palatable food, Nutr. Neurosci. 15 (2012) 1017.
[13] P.O. Prada, P.G. Quaresma, A.M. Caricilli, et al., Tub has a key role in insulin and
leptin signaling and action in vivo in hypothalamic nuclei, Diabetes 62 (2013)
137148.
[14] A.M. Melo, R.O. Benatti, L.M. Ignacio-Souza, et al., Hypothalamic endoplasmic
reticulum stress and insulin resistance in offspring of mice dams fed high-fat
diet during pregnancy and lactation, Metabolism 63 (2014) 682692.
[15] D.F. Bertelli, A. Coope, A.M. Caricilli, et al., Inhibition of 72 kDa inositol polyphosphate 5-phosphatase E improves insulin signal transduction in dietinduced obesity, J. Endocrinol. 217 (2013) 131140.
[16] D.E. Cintra, E.R. Ropelle, J.C. Moraes, et al., Unsaturated fatty acids revert dietinduced hypothalamic inammation in obesity, PLoS One 7 (2012) e30571.
[17] A.A. Bueno, L.M. Oyama, C.S. de Macedo Motoyama, et al., Long chain saturated
fatty acids increase haptoglobin gene expression in C57BL/6J mice adipose
tissue and 3T3-L1 cells, Eur. J. Nutr. 49 (2010) 235241.
[18] D. Estadella, C.M da Penha Oller do Nascimento, L.M. Oyama, et al., Lipotoxicity: effects of dietary saturated and transfatty acids, Mediators Inamm 2013
(2013) 137579, http://dx.doi.org/10.1155/2013/137579.
[19] R. Buettner, J. Schlmerich, L.C. Bollheime, High-fat diets: modeling the
metabolic disorders of human obesity in rodents, Obesity 15 (2007) 798808.
[20] G. Van Meer, S. Hoetzel, Sphingolipid topology and the dynamic organization
and function of membrane proteins, FEBS Lett. 584 (2009) 18001805.
[21] G. Riccardi, R. Giacco, A.A. Rivellese, Dietary fat, insulin sensitivity and the
metabolic syndrome, Clin. Nutr. 23 (2004) 447456.
[22] K. Chechi, G.R. Herzberg, S.K. Cheema, Maternal dietary fat intake during
gestation and lactation alters tissue fatty acid composition in the adult offspring of C57Bl/6 mice, Prostalglandins Leukot Essent Fat. Acids 83 (2010)
97104.
[23] P.E. Wainwright, Dietary essential fatty acids and brain function: a developmental perspective on mechanisms, Proc. Nutr. Soc. 61 (2002) 6169.
[24] Q. Liu, M.A. Smith, J. Avil, et al., Alzheimer-specic epitopes of tau represent
lipid peroxidation-induced conformations, Free Radic. Biol. Med. 38 (2005)
746754.
[25] R.V. Gow, A. Sumich, F. Vallee-Tourangeau, et al., Omega-3 fatty acids are
related to abnormal emotion processing in adolescent boys with attention
decit hyperactivity disorder, Prostaglandins Leukot Essent Fat. Acids 88
(2013) 419429.
[26] K.T. Albuquerque, F.L. Sardinha, M.M. Telles, et al., Intake of trans fatty acidrich hydrogenated fat during pregnancy and lactation inhibits the hypophagic
effect of central insulin in the adult offspring, Nutrition 22 (2006) 820829.
[27] D. Fedor, D.S. Kelley, Prevention of insulin resistance by n-3 polyunsaturated
fatty acids, Curr. Opin. Clin. Nutr. Metab. Care 12 (2009) 138146.
[28] A.A. Bueno, L.M. Oyama, C. Oliveira, et al., Effects of different fatty acids and
dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J
mice adipose tissue, Eur. J. Physiol. 455 (2008) 701709.
[29] M.H. Gaiva, R.C. Couto, L.M. Oyama, et al., Polyunsaturated fatty acid rich diets:
effect on adipose tissue metabolism in rats, Br. J. Nutr. 86 (2001) 371377.
[30] A.A. Bueno, K. Ghebremeskel, K.H. Bakheit, et al., Dimethyl acetals, an indirect
marker of the endogenous antioxidant plasmalogen level, are reduced in
blood lipids of Sudanese pre-eclamptic subjects whose background diet is
high in carbohydrate, J. Obstet. Gynaecol. 32 (2012) 241246.
[31] G. Paxinos, C. Watson, The rat brain in stereotaxic coordinates, Academic Press
Inc., San Diego, 1986.
[32] A. Iuras, M.M. Telles, I.S. Andrade, et al., L-arginine abolishes the hypothalamic
serotonergic activation induced by central interleukin-1 administration to
normal rats, J. Neuroinamm. 10 (2013) 147.
[33] U.K. Laemmli, Cleavage of structural proteins during the assembly of the head
of bacteriophage T4, Nature 15 (1970) 680685.
[34] P. Patel, N. Abate, Body fat distribution and insulin resistance, Nutrients 5
(2013) 20192027.
[35] M.M.J. Van Greevenbroek, C.G. Schalkwijk, C.D.A. Stehouwer, Obesityassociated low-grade inammation in type 2 diabetes mellitus: causes and
consequences, Neth. J. Med. 71 (2013) 174187.
[36] E. Scarpellini, J. Tack, Obesity and metabolic syndrome: an inammatory
condition, Dig. Dis. 30 (2012) 148153.
[37] S.C. Woods, R.J. Seeley, P.A. Rushing, et al., A controlled high-fat diet induces
an obese syndrome in rats, J. Nutr. 133 (2003) 10811087.
[38] A.A. Bueno, L.M. Oyama, C. Oliveira, et al., Effects of different fatty acids and
dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J
mice adipose tissue, Pugers Arch 455 (2008) 701709.
[39] S.J. Guyenet, M.W. Schwartz, Clinical review: Regulation of food intake, energy
balance, and body fat mass: implications for the pathogenesis and treatment
of obesity, J. Clin. Endocrinol. Metab. 97 (2012) 745755.
[40] G. Shillabeer, D.C. Lau, Regulation of new fat cell formation in rats: the role of
dietary fats, J. Lipid Res. 35 (1994) 592600.
[41] R. Buettner, K.G. Parhofer, M. Woenckhaus, et al., Dening high-fat-diet rat
models: metabolic and molecular effects of different fat types, J. Mol. Endocrinol. 36 (2006) 485501.
[42] P. Schrauwen, K.R. Westerterp, The role of high-fat diets and physical activity
in the regulation of body weight, Br. J. Nutr. 84 (2000) 417427.
[43] M.H. Gava, R.C. Couto, L.M. Oyama, et al., Polynsaturated fatty acid-rich diets:
effect on adipose tissue metabolism in rats, Br. J. Nutr. 86 (2001) 371377.
A.P.S. Dornellas et al. / Prostaglandins, Leukotrienes and Essential Fatty Acids 102-103 (2015) 2129
29
[62] E.J. Scholljegerdes, S.L. Lake, T.R. Weston, et al., Fatty acid composition of
plasma, medial basal hypothalamus, and uterine tissue in primiparous beef
cows fed high-linoleate safower seeds, J. Anim. Sci. 85 (2007) 15551564.
[63] M.A. Crawford, The role of dietary fatty acids in biology: their place in the
evolution of the human brain, Nutr. Rev. 50 (1992) 311.
[64] T. Fraser, H. Tayler, S. Love, Fatty acid composition of frontal, temporal and
parietal neocortex in the normal human brain and in Alzheimer's disease,
Neurochem. Res. 35 (2010) 503513.
[65] F.L. Sardinha, M.M. Telles, K.T. Albuquerque, et al., Gender difference in the
effect of intrauterine malnutrition on the central anorexigenic action of insulin
in adult rats, Nutrition 22 (2006) 11521161.
[66] P.O. Prada, H.G. Zecchin, A.L. Gasparetti, et al., Western diet modulates insulin
signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate1ser307 phosphorylation in a tissue-specic fashion, Endocrinology 146
(2005) 15761587.
[67] A.P. Arruda, M. Milanski, A. Coope, et al., Low-grade hypothalamic inammation leads to defective thermogenesis, insulin resistance, and impaired
insulin secretion, Endocrinology 152 (2011) 13141326.
[68] C.T. De Souza, E.P. Araujo, S. Bordin, et al., Consumption of a fat-rich diet
activates a proinammatory response and induces insulin resistance in the
hypothalamus, Endocrinology 146 (2005) 41924199.
[69] D.J. Clegg, K. Gotoh, C. Kemp, et al., Consumption of a high-fat diet induces
central insulin resistance independent of adiposity, Physiol. Behav. 103 (2011)
1016.
[70] J. Downward, Mechanisms and consequences of activation of protein kinase B/
Akt, Curr. Opin. Cell Biol. 10 (1998) 262267.
[71] R. Chen, O. Kim, J. Yang, et al., Regulation of Akt/PKB activation by tyrosine
phosphorilation, J. Biol. Chem. 276 (2001) 3185831862.
[72] E. Carvalho, C. Rondinone, U. Smith, Insulin resistance in fat cells from obese
Zucker rats: evidence for an impaired activation and translocation of protein
kinase B and glucose transporter 4, Mol. Cell. Biochem. 206 (2000) 716.
[73] D.A. Sequea, N. Sharma, E.B. Arias, et al., Calorie restriction enhances insulinstimulated glucose uptake and Akt phosphorylation in both fast-twitch and
slow-twitch skeletal muscle of 24-month-old rats, J. Gereontol. Biol. Sci. Med.
Sci. 67 (2012) 12761285.
[74] A.W. Xu, C.B. Kaelin, K. Takeda, et al., PI3K integrates the action of insulin and
leptin on hypothalamic neurons, J. Clin. Investig. 115 (2005) 951958.
[75] C.M. Mayer, D.D. Belsham, Insulin directly regulates NPY and AgRP gene
expression via the MAPK MEK/ERK signal transduction pathway in mHypoE46 hypothalamic neurons, Mol. Cell. Endocrinol. 307 (2009) 99108.
[76] E.R. Ropelle, J.R. Pauli, P.O. Prada, et al., Inhibition of hypothalamic Foxo1
expression reduced food intake in diet-induced obesity rats, J. Physiol. 587
(2009) 23412351.
[77] L.A. Velloso, The hypothalamic control of feeding and thermogenesis: implications on the development of obesity, Arq. Bras. Endocrinol. Metab. 50 (2006)
165176.